Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02616393
Brief Title: Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases

First Submitted : November 20, 2015
First Submitted that Met QC Criteria : November 24, 2015
First Posted : November 26, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 16, 2020
Last Update Posted : January 21, 2020